2024年全球新药研发趋势

The IQVIA Institute for Human Data Science has released a report on global trends in R&D for 2024. The report assesses the trends in new drug launches and the overall number of initiated clinical trials, as well as the state of R&D funding and the activity of companies of different types. The report also examines the notable acceleration and adaptability of the innovation ecosystem in terms of several enablers of R&D productivity, including the relationship between shortening trial durations and the 'white space' within clinical development timelines. The research was undertaken independently by the IQVIA Institute for Human Data Science as a public service, without industry or government funding. The analytics in the report are based on proprietary IQVIA databases and/or third-party information and are not derived from proprietary sponsor trial information.